iAnthus Capital Holdings (iAnthus Capital Holdings) Risk Assessment

View and export this data going back to 2016. Start your Free Trial

What is iAnthus Capital Holdings Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of iAnthus Capital Holdings is: No Data: Cannot be evaluated.

Competitive Comparison of iAnthus Capital Holdings's Risk Assessment

For the Drug Manufacturers - Specialty & Generic subindustry, iAnthus Capital Holdings's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

iAnthus Capital Holdings's Risk Assessment Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, iAnthus Capital Holdings's Risk Assessment distribution charts can be found below:

* The bar in red indicates where iAnthus Capital Holdings's Risk Assessment falls into.

iAnthus Capital Holdings (OTCPK:ITHUF) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

iAnthus Capital Holdings Risk Assessment Related Terms

Thank you for viewing the detailed overview of iAnthus Capital Holdings's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

iAnthus Capital Holdings (iAnthus Capital Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » iAnthus Capital Holdings Inc (OTCPK:ITHUF) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

2IA:Germany IAN:Canada

Address

420 Lexington Avenue, Suite 414, New York, NY, USA, 10170

Website

https://www.ianthus.com

iAnthus Capital Holdings Inc owns and operates licensed cannabis cultivators, processors, and dispensaries throughout the United States. The company's operating segments include the Eastern Region and Western Region. It generates a majority of its revenue from the Eastern Region. The Eastern Region includes the company's operations in Florida, Maryland, Massachusetts, New York, New Jersey, Vermont, and its CBD business. Its Western Region includes the company's operations in Arizona, Colorado, and Nevada.

Executives

Proud Richard C. Jr.	director, officer: CEO and Director	8253 PARSONS PASS, NEW ALBANY OH 43054
Alexander Shoghi	director	SUITE 1550, 300 WEST 6TH STREET, AUSTIN TX 78701
John Alexander Paterson	director	2 WENDIGO WAY, TORONTO A6 M6S2T9
Gotham Green Partners Llc	10 percent owner	1437 4TH STREET, SANTA MONICA CA 90401
Philippe Faraut	officer: Chief Financial Officer	420 LEXINGTON AVENUE, SUITE 414, NEW YORK NY 10170
Kenneth W Gilbert	director	C/O THE WENDY'S COMPANY, ONE DAVE THOMAS BLVD., DUBLIN OH 43017
Julius Kalcevich	officer: Chief Financial Officer	420 LEXINGTON AVENUE, SUITE 414, NEW YORK NY 10170
Robert R Galvin	officer: Interim CEO and COO
Senvest Management, Llc	director, 10 percent owner, other: (See Remarks)	540 MADISON AVENUE, 32ND FLOOR, NEW YORK NY 10022
Marco Dattanasio	director	420 LEXINGTON AVENUE, SUITE 414, NEW YORK NY 10170
Scott Herman Cohen	director	420 LEXINGTON AVENUE, SUITE 414, NEW YORK NY 10170
Zachary Arrick	director	420 LEXINGTON AVENUE, SUITE 414, NEW YORK NY 10170
Mich J Mathews-spradlin	director	ONE DAVE THOMAS BLVD., DUBLIN OH 43017
Oasis Investments Ii Master Fund Ltd.	10 percent owner	UGLAND HOUSE PO BOX 309, GRAND CAYMAN E9 KY1-1104
Seth Fischer	10 percent owner	C/O OASIS MANAGEMENT (HONG KONG) LLC, 21/F MAN YEE BUILDING, 68 DES VOEUX ROAD, CENTRAL K3